
Call us
07971549588
Linagliptin 5 mg and Dapagliflozin 10 mg, marketed under the name LINALIGLIP DAPA 5-10, is a combination medication used to manage type 2 diabetes. This medication combines the benefits of Linagliptin, a DPP-4 inhibitor, and Dapagliflozin, an SGLT2 inhibitor, to effectively control blood glucose levels and improve overall glycemic management.
Price: